title: Guidelines for prescribing combined oral contraceptives.
authors.forename: A M
authors.initials: AM
authors.lastname: Mills
authors.forename: C L
authors.initials: CL
authors.lastname: Wilkinson
authors.forename: D R
authors.initials: DR
authors.lastname: Bromham
authors.forename: J
authors.initials: J
authors.lastname: Elias
authors.forename: K
authors.initials: K
authors.lastname: Fotherby
authors.forename: J
authors.initials: J
authors.lastname: Guillebaud
authors.forename: A
authors.initials: A
authors.lastname: Kubba
authors.forename: A
authors.initials: A
authors.lastname: Wade
mesh_terms: D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects; D017135:Desogestrel / Q000009:adverse effects; D011307:Drug Prescriptions; D006801:Humans; D009652:Norpregnenes / Q000009:adverse effects; D017410:Practice Guidelines as Topic; D012306:Risk; D013923:Thromboembolism / Q000139:chemically induced
chemical_list: D003277:Contraceptives, Oral, Combined; D003280:Contraceptives, Oral, Synthetic; D009652:Norpregnenes; C033273:Gestodene; D017135:Desogestrel